Skip to main content

Table 3 Statistically significant associations of KLRG1 expression and other clinicopathologic variables with progression-free survival

From: Functions and clinical significance of KLRG1 in the development of lung adenocarcinoma and immunotherapy

Outcome

PFS

HR

95%CI

P value

KLRG1 expression level (High vs. Low)

0.139

0.029–0.668

0.014

Drug (Nivolumab vs. Pembrolizumab)

8.781

1.332–57.878

0.024

Biopsy (Archival vs. Baseline)

0.248

0.094–1.842

0.248

Smoking history (Current smoker & Former smoker vs. Never smoker)

2.930

0.311–27.575

0.347

Gender (Male vs. Female)

0.263

0.048–1.447

0.125

Age (< 58 vs. ≥58)

0.417

0.110–1.579

0.198

ECOG (0 vs. 1)

0.480

0.093–2.480

0.381

  1. P values are derived from Cox regression analysis